15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The mammalian mid-pachytene checkpoint: meiotic arrest in spermatocytes with a mutation in Atm alone or in combination with a Trp53 (p53) or Cdkn1a (p21/cip1) mutation.

      Cytogenetic and Genome Research
      Animals, Apoptosis, Ataxia Telangiectasia Mutated Proteins, Cell Cycle Proteins, genetics, metabolism, Cyclin-Dependent Kinase Inhibitor p21, DNA-Binding Proteins, deficiency, Female, Male, Meiosis, Mice, Mutation, Protein-Serine-Threonine Kinases, Rad51 Recombinase, Spermatocytes, cytology, Tumor Suppressor Protein p53, Tumor Suppressor Proteins

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          ATM, the protein product of the gene mutated in the human autosomal recessive disorder ataxia telangiectasia, is involved in detection of double strand breaks (DSBs) and is a key component of the damage surveillance network of cell cycle proteins. In somatic cells ATM phosphorylates many other proteins including p53, an important regulator of cell cycle control. Mice deficient for Atm are male sterile with arrest and apoptosis occurring at testis epithelial stage IV, which in normal spermatocytes corresponds to mid-pachynema. Unlike the situation in somatic cells, we find no evidence that disruption of the Trp53 (p53) gene, or its down-stream target Cdkn1a (p21/Cip1) results in even a partial rescue of the Atm defect. Copyright 2004 S. Karger AG, Basel.

          Related collections

          Author and article information

          Comments

          Comment on this article